Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory diffuse large B-cell lymphoma
莫苏妥珠单抗单药治疗对复发/难治性弥漫性大B细胞淋巴瘤患者有效且耐受性良好
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2022009260
Bartlett, Nancy L; Assouline, Sarit; Giri, Pratyush; Schuster, Stephen J; Cheah, Chan Y; Matasar, Matthew; Gregory, Gareth P; Yoon, Dok Hyun; Shadman, Mazyar; Fay, Keith; Yoon, Sung-Soo; Panizo, Carlos; Flinn, Ian; Johnston, Anna; Bosch, Francesc; Sehn, Laurie H; Wei, Michael C; Yin, Shen; To, Iris; Li, Chi-Chung; Huang, Huang; Kwan, Antonia; Penuel, Elicia; Budde, Lihua E